References
- Gawin F H, Kleber H D, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117–21
- Levin F R, Lehman AF. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharm 1991; 11: 374–378
- Halikas J A, Kemp K, Kuhn K, et al. Carbamazepine for cocaine addiction. Lancet 1989; 1: 623–624
- Berger P, Gawin F, Kosten TR. Treatment of cocaine abuse with mazindol (letter). Lancet 1989; 4: 283
- Kosten T R, Kleber H D, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 1989; 44: 887–892
- Gawin F H, Allen D, Humblestone B. Outpatient treatment of “crack” cocaine smoking with flupen-thixol decanoate: a preliminary report. Arch Gen Psychiatry 1989; 46: 322–325
- Pollack M H, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52: 31–33
- Margolin A, Kosten T, Petrakis I, et al. Bupropion reduces cocaine abuse in methadone-maintained patients (letter). Arch Gen Psychiatry 1991; 48: 87
- Weddington WW. Use of unproven and unapproved drugs to treat cocaine addiction (letter). Am J Psychiatry 1990; 147: 1576
- Rosen H, Flamanbaum A, Slater VL. Clinical trial of carbidopa-L-dopa combination for cocaine abuse (letter). Am J Psychiatry 1986; 143: 1493
- Roehrich S, Dackis C, Gold M. Bromocriptine. Med Res Rev 1987; 7: 243–269
- Giannini A J, Baumgartel P, DiMarzio IX. Bromocriptine therapy in cocaine withdrawal. J Clin Pharmacol 1987; 27: 267–270
- Giannini A J, Billett W. Bromocriptine-desipramine protocol in treatment of cocaine addiction. J Clin Psychiatry 1987; 27: 549–554
- Teller DW, Devenyi P. Bromocriptine in cocaine withdrawal-does it work?. Intl J Addictions 1988; 23: 1197–1205
- Tennant F S, Sagherian AA. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal for cocaine dependence. Arch Intern Med 1987; 147: 109–112
- Gawin F H, Morgan C, Kosten T R, et al. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology 1989; 97: 402–403
- Weddington W W, Brown B S, Haertzen C A, et al. Comparison of amantadine and desipramine com-Pergolide and Bromocriptine bined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17: 137–152
- Goldstein M, Lieberman A, Lew J W, et al. Interaction of pergolide with central dopaminergic receptors. Proc Nad Acad Sci USA 1980; 77: 3725–3728
- Watchel H. Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans. J Neural Transm 1991; 3: 151–201
- Malcolm R, Hutto B R, Phillips J D, et al. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry 1991; 52: 39–40
- Langtry H, Clissold S. Pergolide review of its pharmacological properties and therapeutic potential in Parkinson's disease. Drugs 1990; 39: 491–506
- Brady K, Anton R, Ballenger JC, et al. Cocaine abuse among schizophrenic patients (case report). Am J Psychiatry 1990; 147: 9
- Weddington W, Brown S, Haertzen C, et al. Changes in mood, craving, and sleep during short-term reported by male cocaine addicts. Arch Gen Psychiatry 1990; 47: 861–868
- Satel S L, Price L H, Palumbo J M, et al. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991; 148: 1712–1716
- Kang S, Kleiman P, Woody G, et al. Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am J Psychiatry 1991; 148: 630–635
- Strickler H, Martin C, Sowell R, et al. A comparison of alcoholics and cocaine addicts one year following inpatient treatment. J Med Assoc Ga 1987; 76: 751–756